Development and validation of a reversed-phase HPLC method for the estimation of zolpidem in bulk drug and tablets

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the present study an isocratic reversed-phase high-performance liquid chromatography method was developed for the estimation of zolpidem in bulk drug and pharmaceutical dosage forms. The quantification was carried out on C 18 columns. A mixture of acetonitrile-ammonium acetate (pH = 8.0, 0.02 M) (60: 40 v/v) was used as the mobile phase, at flow rate of 1.0 mL/min and the determination wavelength at 245 nm. The retention time of zolpidem was found to be 3-5 min. The validation of the proposed method was carried out for specificity, linearity, accuracy, precision, limit of detection, limit of quantification, and robustness. The linear dynamic range was from 2.5 to 30 μg mL -1. Regression equation was found to be y = 0.1416 x + 0.0183 with correlation coefficient r = 0.9996. The percentage recovery obtained for zolpidem was greater than 96.5. Limit of quantification and limit of detection were found to be 2.5 μg mL -1 and 0.83 μg mL -1, respectively. The developed method can be used for routine quality control analysis of zolpidem in tablet formulations. © 2013 E. Konoz et al.

Cite

CITATION STYLE

APA

Konoz, E., Mohsen Sarrafi, A. H., Abdolahnejad, R., & Bahrami-Zonoz, M. (2013). Development and validation of a reversed-phase HPLC method for the estimation of zolpidem in bulk drug and tablets. Journal of Chemistry. https://doi.org/10.1155/2013/357890

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free